IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 14 filers reported holding IMMUNOMEDICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $23,907,000 | +21.2% | 12,990,000 | -7.1% | 0.02% | +11.1% |
| Q1 2017 | $19,718,000 | +98.2% | 13,990,000 | +40.0% | 0.02% | +80.0% |
| Q4 2016 | $9,948,000 | -20.9% | 9,990,000 | -28.6% | 0.01% | -23.1% |
| Q3 2016 | $12,571,000 | +28.9% | 13,990,000 | 0.0% | 0.01% | +18.2% |
| Q2 2016 | $9,749,000 | +2.4% | 13,990,000 | +0.6% | 0.01% | -8.3% |
| Q1 2016 | $9,517,000 | – | 13,900,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,000,000 | $18,404,000 | 2.40% |
| Castle Creek Arbitrage, LLC | 5,512,000 | $10,097,000 | 1.08% |
| Orbimed Advisors | 30,000,000 | $54,794,000 | 0.57% |
| Graham Capital Management, L.P. | 7,000,000 | $12,833,000 | 0.34% |
| WOLVERINE ASSET MANAGEMENT LLC | 10,010,000 | $18,308,000 | 0.23% |
| LAZARD ASSET MANAGEMENT LLC | 16,000,000 | $29,320,000 | 0.06% |
| Jefferies Group LLC | 3,889,000 | $7,100,000 | 0.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 535,000 | $982,000 | 0.04% |
| Paloma Partners Management Co | 1,500,000 | $2,744,000 | 0.03% |
| Citadel Advisors | 12,990,000 | $23,907,000 | 0.02% |